Shanghai Pharmaceuticals Holding Co Ltd banner

Intrinsic Value

The intrinsic value of Shanghai Pharmaceuticals Holding Co Ltd (SHPMF) under the Base Case is 2.46 USD per share. Compared with the current market price of 1.46 USD, the stock appears Undervalued by 41% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SHPMF Intrinsic Value
$2.46
Undervaluation 41%
Intrinsic Value
Price $1.46
Alert me when SHPMF is below its intrinsic value
Today $1.23 · 15.8% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to SHPMF

Fundamental Analysis

What Shanghai Pharmaceuticals Does

Health Care

Shanghai Pharmaceuticals Holding is a Chinese healthcare company that does two main jobs: it makes medicines and it distributes them. On the manufacturing side, it develops and produces prescription drugs, over-the-counter products, and traditional Chinese medicine products. On the distribution side, it moves medicines and healthcare products through hospitals, retail pharmacies, and other medical channels.

Headquarters
China CN
Employees
49 608
IPO date
Mar 24, 1994
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Shanghai Pharmaceuticals Holding Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one SHPMF stock?

The intrinsic value for Shanghai Pharmaceuticals Holding Co Ltd (SHPMF) under the Base Case is 2.46 USD.

Is SHPMF stock undervalued or overvalued?

Compared with the current market price of 1.46 USD, the stock appears Undervalued by 41% .

Back to Top